We track the following information for you:
-the top RCC institutions: MSKCC, DFCI, BIDMC, UTSW, etc.
-the top trials: NKTR, Pembo/Axi, Avel/Axi, HERVE-TCR, AM0010, Cabo/Nivo, Tivo, etc.
-the future: CAR NK, Microbiome, killer engagers, YAP, YAZ, CPG Oligonucleotide, TriKEs, etc.
-the top targets: CD 3 CD 40, CD 70, CD 73, etc.
-the top cancer biotech firms: Acro, Tikcro, Sutro, Regeneron, Batu,Peloton, etc.
-the top cancer genes: PBRM1, BAP1, EZH2, etc.
-the top conferences: ASCO, ESMO, AUA, AACR, SITC, ASTRO, etc.
-the top novel agents: HIF, Glutaminase, IL10, Adenosine, CXCR4, Neoantigen peptides, LAG3, etc.
-the top RCC surgeons and oncologists
If you want us to track something for you, send us an email.
Disclaimer:
The material in this newsletter is for informational purposes only and is not a substitute for professional medical advice.
consult with a qualified healthcare provider with any questions or concerns you may have.